[1] |
Siegel RS, Pandolfino T, Guitart J, et al. Primary cutaneous T⁃cell lymphoma: review and current concepts[J]. J Clin Oncol, 2000,18(15):2908⁃2925. doi: 10.1200/JCO.2000.18.15.2908.
|
[2] |
Zhang Y, Wang Y, Yu R, et al. Molecular markers of early⁃stage mycosis fungoides[J]. J Invest Dermatol, 2012,132(6):1698⁃1706. doi: 10.1038/jid.2012.13.
|
[3] |
Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)[J]. Blood, 2007,110(6):1713⁃1722. doi: 10.1182/blood⁃2007⁃03⁃055749.
|
[4] |
Fromowitz FB, Viola MV, Chao S, et al. ras p21 expression in the progression of breast cancer[J]. Hum Pathol, 1987,18(12):1268⁃1275. doi: 10.1016/s0046⁃8177(87)80412⁃4.
|
[5] |
Sabattini E, Bacci F, Sagramoso C, et al. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview [J]. Pathologica. 2010,102(3):83⁃87.
|
[6] |
Yu X, Luo Y, Liu J, et al. TOX acts an oncological role in mycosis fungoides[J]. PLoS One, 2015,10(3):e0117479. doi: 10.1371/journal.pone.0117479.
|
[7] |
Schrader AM, Jansen PM, Willemze R. TOX expression in cutaneous T⁃cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+) CD8(⁃) phenotype[J]. Br J Dermatol, 2016,175(2):382⁃386. doi: 10.1111/bjd.14508.
|
[8] |
Wilkinson B, Chen JY, Han P, et al. TOX: an HMG box protein implicated in the regulation of thymocyte selection[J]. Nat Immunol, 2002,3(3):272⁃280. doi: 10.1038/ni767.
|
[9] |
Morimura S, Sugaya M, Suga H, et al. TOX expression in different subtypes of cutaneous lymphoma[J]. Arch Dermatol Res, 2014,306(9):843⁃849. doi: 10.1007/s00403⁃014⁃1501⁃7.
|
[10] |
Boonk SE, Çetinözman F, Vermeer MH, et al. Differential expression of TOX by skin⁃infiltrating T cells in Sézary syndrome and erythrodermic dermatitis[J]. J Cutan Pathol, 2015,42(9):604⁃609. doi: 10.1111/cup.12490.
|
[11] |
Schrader AM, Jansen PM, Willemze R. TOX expression in cutaneous B⁃cell lymphomas[J]. Arch Dermatol Res, 2016,308(6):423⁃427. doi: 10.1007/s00403⁃016⁃1654⁃7.
|
[12] |
Hsiao PF, Hsiao CH, Lin YC, et al. Histopathologic⁃molecular correlation in early mycosis fungoides using T⁃cell receptor gamma gene rearrangement by polymerase chain reaction with laser capture microdissection[J]. J Formos Med Assoc, 2007,106(4):265⁃272. doi: 10.1016/S0929⁃6646(09)60251⁃5.
|
[13] |
Simone NL, Bonner RF, Gillespie JW, et al. Laser⁃capture microdissection: opening the microscopic frontier to molecular analysis[J]. Trends Genet, 1998,14(7):272⁃276. doi: 10.1016/s0168⁃9525(98)01489⁃9.
|
[14] |
Yang H, Xu C, Tang Y, et al. The significance of multiplex PCR/heteroduplex analysis⁃based TCR⁃γ gene rearrangement combined with laser⁃capture microdissection in the diagnosis of early mycosis fungoides[J]. J Cutan Pathol, 2012,39(3):337⁃346. doi: 10.1111/j.1600⁃0560.2011.01842.x.
|
[15] |
Wood GS, Haeffner A, Dummer R, et al. Molecular biology techniques for the diagnosis of cutaneous T⁃cell lymphoma[J]. Dermatol Clin, 1994,12(2):231⁃241.
|
[16] |
Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T⁃cell receptor gamma gene rearrangements in early mycosis fungoides/Sézary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE)[J]. J Invest Dermatol, 1994,103(1):34⁃41. doi: 10.1111/1523⁃1747.ep12389114.
|
[17] |
Ashton⁃Key M, Diss TC, Du MQ, et al. The value of the polymerase chain reaction in the diagnosis of cutaneous T⁃cell infiltrates[J]. Am J Surg Pathol, 1997,21(7):743⁃747. doi: 10. 1097/00000478⁃199707000⁃00001.
|